1513.HKライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (2 5月 2024 @ 17:08):

Stats
本日の出来高	544 590
平均出来高	682 673
時価総額	35.53B
EPS	HKD0.500 ( 2023-10-24 )
Last Dividend	HKD1.744 ( 2023-07-04 )
Next Dividend	HKD0 ( N/A )
P/E	11.85
ATR14	HKD0.0470 (0.17%)

ボリューム相関

長: 0.45 (neutral)

短: -0.30 (neutral)

Signal:(43.222) Neutral

Livzon Pharmaceutical 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Livzon Pharmaceutical 相関 - 通貨/商品

0.80
( moderate )

0.86
( strong )

0.00
( neutral )

0.75
( moderate )

-0.77
( moderate negative )

-0.67
( moderate negative )

Livzon Pharmaceutical 財務諸表

Annual	2023
収益:	HKD12.43B
総利益:	HKD7.96B (64.08 %)
EPS:	HKD2.10

FY	2023
収益:	HKD12.43B
総利益:	HKD7.96B (64.08 %)
EPS:	HKD2.10

FY	2022
収益:	HKD12.63B
総利益:	HKD8.17B (64.68 %)
EPS:	HKD2.04

FY	2021
収益:	HKD12.06B
総利益:	HKD7.81B (64.75 %)
EPS:	HKD1.900

Financial Reports:

No articles found.

Livzon Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD1.744 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Livzon Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.75 - Stable (14.96%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.221	2014-07-08
Last Dividend	HKD1.744	2023-07-04
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	10	--
Total Paid Out	HKD9.31	--
Avg. Dividend % Per Year	0.00%	--
Score	2.98	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.75
Div. Directional Score	7.94	--

Next Divdend (Est)
(2024-06-24)

HKD1.912 Estimate 3.11 %

Dividend Stability

0.25 Very Poor

Dividend Score

2.98

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
6066.HK	Ex Dividend Junior	2023-07-03	Annually	0.00%
1830.HK	Ex Dividend Knight	2023-08-16	Annually	0.00%
0857.HK	Ex Dividend Knight	2023-09-12	Semi-Annually	0.00%
0010.HK	Ex Dividend Knight	2023-09-12	Semi-Annually	0.00%
2607.HK	Ex Dividend Junior	2023-07-18	Annually	0.00%
1398.HK	Ex Dividend Knight	2023-07-06	Annually	0.00%
0467.HK	Ex Dividend Junior	2023-07-18	Annually	0.00%
6833.HK	Ex Dividend Junior	2023-05-31	Sporadic	0.00%
1953.HK	Ex Dividend Junior	2023-07-05	Annually	0.00%
0984.HK	Ex Dividend Junior	2023-10-03	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.161	1.500	6.77	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0786	1.200	7.38	8.86	[0 - 0.3]
returnOnEquityTTM	0.142	1.500	9.53	10.00	[0.1 - 1]
payoutRatioTTM	0.799	-1.000	2.01	-2.01	[0 - 1]
currentRatioTTM	2.06	0.800	4.69	3.75	[1 - 3]
quickRatioTTM	1.802	0.800	4.11	3.29	[0.8 - 2.5]
cashRatioTTM	1.338	1.500	3.68	5.52	[0.2 - 2]
debtRatioTTM	0.141	-1.500	7.64	-10.00	[0 - 0.6]
interestCoverageTTM	24.70	1.000	1.962	1.962	[3 - 30]
operatingCashFlowPerShareTTM	3.15	2.00	8.95	10.00	[0 - 30]
freeCashFlowPerShareTTM	2.27	2.00	8.87	10.00	[0 - 20]
debtEquityRatioTTM	0.244	-1.500	9.02	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.645	1.000	2.58	2.58	[0.2 - 0.8]
operatingProfitMarginTTM	0.206	1.000	7.88	7.88	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.827	1.000	6.51	6.51	[0.2 - 2]
assetTurnoverTTM	0.487	0.800	-0.0887	-0.0709	[0.5 - 2]
Total Score				10.13

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	11.55	1.000	8.93	0	[1 - 100]
returnOnEquityTTM	0.142	2.50	9.70	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	2.27	2.00	9.24	10.00	[0 - 30]
dividendYielPercentageTTM	7.13	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.15	2.00	8.95	10.00	[0 - 30]
payoutRatioTTM	0.799	1.500	2.01	-2.01	[0 - 1]
pegRatioTTM	0.404	1.500	-0.637	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.241	1.000	6.49	0	[0.1 - 0.5]
Total Score				5.75

Livzon Pharmaceutical

Livzon Pharmaceutical Group Inc. engages in the research, development, production, and sale of pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People's Republic of China. The company offers Ilaprazole enteric coated tablets for the treatment of duodenal ulcers and reflux esophagitis; Laprazole sodium for injection to treat peptic ulcer hemorrhage; Leuprorelin Acetate Microspheres for injection; Urofollitropin for injection to treat anovulation and sufferers; Perospirone Hydrochloride for the treatment of schizophrenia; Anti-viral Granules to treat upper respiratory tract infection and influenza; and Shenqi Fuzheng Injection for the treatment of weakness and tiredness, lassitude, spontaneous sweating, and vertigo, as well as for the patients of lung and stomach cancer. It also offers diagnostic reagents, such as diagnostic kit for IgM/IgG antibody to coronavirus; nucleic acid test kit for human immunodeficiency virus type 1; antinuclear antibody test kits; interferon-gamma release assays test kits; and rapid test for mycoplasma pneumoniae IgM antibody. In addition, the company provides biochemical drugs, microbiological preparations, biologic products, Chinese drug preparations and pharmaceutical raw materials, and antibiotics. It also exports its products. The company was founded in 1985 and is headquartered in Zhuhai, China.